CIK: 0001892134 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 13, 2026
Total Value ($000): $3,723,154 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT THERAPEUTICS INC | 983,333 | $33,305 | 0.9% | $31.06 | 0.0% | COM NEW | 75382E208 |
| VOR | VOR BIOPHARMA INC | 2,543,939 | $33,275 | 0.9% | $18.62 | 0.0% | COM NEW | 929033207 |
| MNKD | MANNKIND CORP | 4,225,000 | $23,956 | 0.6% | $5.51 | 0.0% | COM NEW | 56400P706 |
| XLO | XILIO THERAPEUTICS INC | 5,915,091 | $3,787 | 0.1% | $0.75 | 0.0% | COM | 98422T100 |
| IBIO | IBIO INC | 1,953,467 | $3,770 | 0.1% | $1.36 | 0.0% | COM NEW | 451033708 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 16,943,774 (+1.4%) | $594,388 (+25.1%) | 16.0% | $13.41 | +171.4% | ORDINARY SHARES | N62509109 |
| RNA | AVIDITY BIOSCIENCES INC | 983,125 (+57.3%) | $70,913 (+160.4%) | 1.9% | $43.19 | +49.5% | COM | 05370A108 |
| DYN | DYNE THERAPEUTICS INC | 3,153,082 (+16.0%) | $61,674 (+79.4%) | 1.7% | $13.76 | +37.6% | COM | 26818M108 |
| ZLAB | ZAI LAB LTD | 1,902,320 (+16.9%) | $33,557 (-39.2%) | 0.9% | $32.50 | — | ADR | 98887Q104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,297,198 (+111.3%) | $34,648 (+164.5%) | 0.9% | $23.78 | +0.5% | COM | 004225108 |
| CYTK | CYTOKINETICS INC | 934,642 (+5.0%) | $59,387 (+21.3%) | 1.6% | $38.38 | +62.1% | COM NEW | 23282W605 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | VERONA PHARMA PLC | 3,383,950 | $361,101 | 9.7% | $15.88 | — | — | 925050106 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 983,715 | $29,590 | 0.8% | $42.43 | -22.5% | — | 90400D108 |
| MREO | MEREO BIOPHARMA GROUP PLC | 9,440,112 | $19,447 | 0.5% | $3.10 | — | — | 589492107 |
| — | AKERO THERAPEUTICS INC | 366,784 | $17,415 | 0.5% | $53.36 | — | — | 00973Y108 |
| PCVX | VAXCYTE INC | 474,405 | $17,088 | 0.5% | $21.85 | +104.7% | — | 92243G108 |
| JBIO | JADE BIOSCIENCES INC | 1,413,280 | $12,197 | 0.3% | $33.31 | -64.8% | — | 008064206 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 456,249 | $11,680 | 0.3% | $21.94 | +46.8% | — | 045396207 |
| — | ADVERUM BIOTECHNOLOGIES INC | 2,077,431 | $9,411 | 0.3% | $5.73 | — | — | 00773U207 |
| ENGN | ENGENE HOLDINGS INC | 1,157,380 | $7,905 | 0.2% | $4.56 | +75.7% | — | 29286M105 |
| MGNX | MACROGENICS INC | 3,175,665 | $5,335 | 0.1% | $6.90 | -77.2% | — | 556099109 |
| SLN | SILENCE THERAPEUTICS PLC | 970,130 | $5,035 | 0.1% | $19.61 | — | — | 82686Q101 |
| CBIO | CRESCENT BIOPHARMA INC. | 272,951 | $3,245 | 0.1% | $21.15 | -39.8% | — | G2545C104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBIO | BRIDGEBIO PHARMA INC | 3,545,557 (-7.8%) | $271,200 (+35.8%) | 7.3% | $21.54 | +204.7% | COM | 10806X102 |
| SVRA | SAVARA INC | 9,862,301 (-14.0%) | $59,470 (+45.3%) | 1.6% | $3.69 | +32.9% | COM | 805111101 |
| RVMD | REVOLUTION MEDICINES INC | 797,455 (-20.1%) | $63,517 (+36.4%) | 1.7% | $25.35 | +158.7% | COM | 76155X100 |
| DSGN | DESIGN THERAPEUTICS INC | 521,000 (-73.3%) | $4,887 (-66.8%) | 0.1% | $4.24 | +84.5% | COM | 25056L103 |
| TARS | TARSUS PHARMACEUTICALS INC | 728,644 (-37.6%) | $59,661 (-14.0%) | 1.6% | $17.82 | +318.9% | COM | 87650L103 |
| IRON | DISC MEDICINE INC | 1,260,000 (-12.4%) | $100,057 (+5.3%) | 2.7% | $35.82 | +135.9% | COM | 254604101 |
| KRYS | KRYSTAL BIOTECH INC | 488,460 (-29.1%) | $120,425 (-0.9%) | 3.2% | $64.17 | +228.0% | COM | 501147102 |
| TVTX | TRAVERE THERAPEUTICS INC | 241,592 (-38.4%) | $9,231 (-1.5%) | 0.2% | $16.57 | +96.2% | COM | 89422G107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9,874,511 | $286,756 | 7.7% | $16.74 | +52.9% | COM | 03969K108 |
| MBX | MBX BIOSCIENCES INC | 6,652,013 | $209,804 | 5.6% | $21.92 | +10.7% | COM | 55287L101 |
| MAZE | MAZE THERAPEUTICS INC | 4,567,274 | $189,222 | 5.1% | $11.88 | +189.3% | COM | 578784100 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 12,466,489 | $206,819 | 5.6% | $12.14 | +17.6% | COM | 71722W107 |
| MIRM | MIRUM PHARMACEUTICALS INC | 6,795,121 | $536,747 | 14.4% | $24.28 | +195.7% | COM | 604749101 |
| ERAS | ERASCA INC | 22,729,436 | $84,554 | 2.3% | $2.19 | +28.5% | COM | 29479A108 |
| TRVI | TREVI THERAPEUTICS INC | 10,259,409 | $128,448 | 3.4% | $2.91 | +296.9% | COM | 89532M101 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 722,400 | $75,614 | 2.0% | $16.23 | +425.5% | COM | 697947109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 5,039,867 | $81,394 | 2.2% | $10.00 | +32.4% | COM | 483497103 |
| ABVX | ABIVAX SA | 378,300 | $51,016 | 1.4% | $84.90 | — | SPONSORED ADS | 00370M103 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,279,754 | $34,835 | 0.9% | $31.94 | +9.8% | COM | 00847X104 |
| LXEO | LEXEO THERAPEUTICS INC | 4,424,725 | $43,938 | 1.2% | $5.15 | +77.1% | COM | 52886X107 |
| VALN | VALNEVA SE | 2,291,666 | $20,212 | 0.5% | $8.03 | — | SPONSORED ADS | 92025Y103 |
| AURA | AURA BIOSCIENCES INC | 5,100,000 | $27,795 | 0.7% | $5.85 | +1.5% | COM | 05153U107 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 500,333 | $11,508 | 0.3% | $0.87 | — | *W EXP 99/99/999 | N62509117 |
| ASND | ASCENDIS PHARMA A/S | 133,333 | $28,432 | 0.8% | $149.31 | — | SPONSORED ADR | 04351P101 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 4,623,324 | $9,200 | 0.2% | $4.59 | — | SPON ADS | 05280R100 |
| ALKS | ALKERMES PLC | 700,647 | $19,604 | 0.5% | $27.95 | +7.2% | SHS | G01767105 |
| EOLS | EVOLUS INC | 2,630,665 | $17,494 | 0.5% | $10.05 | -32.6% | COM | 30052C107 |
| IMCR | IMMUNOCORE HLDGS PLC | 384,782 | $13,356 | 0.4% | $31.23 | — | ADS | 45258D105 |
| ALLO | ALLOGENE THERAPEUTICS INC | 3,868,750 | $5,300 | 0.1% | $3.58 | -63.2% | COM | 019770106 |